673 results on '"Hanby, Andrew"'
Search Results
2. A blind validation of a deep-learning solution providing HER2, ER, and PR results from H&E-stained breast cancer specimens.
3. Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme
4. Inhibition of interferon-signalling halts cancer-associated fibroblast-dependent protection of breast cancer cells from chemotherapy
5. Identification of candidate mediators of chemoresponse in breast cancer through therapy-driven selection of somatic variants
6. Levels of different subtypes of tumour-infiltrating lymphocytes correlate with each other, with matched circulating lymphocytes, and with survival in breast cancer
7. Pan-cancer image-based detection of clinically actionable genetic alterations
8. Neoadjuvant Endocrine Therapy in Breast Cancer Upregulates the Cytotoxic Drug Pump ABCG2/BCRP, and May Lead to Resistance to Subsequent Chemotherapy
9. Genetic predisposition to in situ and invasive lobular carcinoma of the breast.
10. Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project
11. Modelling the Molecular Pathology of Breast Cancer Initiation
12. The Molecular Pathology of Chemoresistance During the Therapeutic Response in Breast Cancer
13. The Molecular Pathology of Male Breast Cancer
14. Fibroepithelial neoplasms of the breast
15. APC Mutations Are Sufficient for the Growth of Early Colorectal Adenomas
16. Imaging Protein Kinase Cα Activation in Cells
17. Harnessing citizen science through mobile phone technology to screen for immunohistochemical biomarkers in bladder cancer
18. MED12, TERT promoter and RBM15 mutations in primary and recurrent phyllodes tumours
19. Data from Genomic and Expression Analyses Define MUC17 and PCNX1 as Predictors of Chemotherapy Response in Breast Cancer
20. Table S3 from Genomic and Expression Analyses Define MUC17 and PCNX1 as Predictors of Chemotherapy Response in Breast Cancer
21. Fig S1-4; Table S1, S2, S4 and S5; S methods from Genomic and Expression Analyses Define MUC17 and PCNX1 as Predictors of Chemotherapy Response in Breast Cancer
22. High Level Expression of p27kip1 and Cyclin D1 in Some Human Breast Cancer Cells: Inverse Correlation between the Expression of p27kip1 and Degree of Malignancy in Human Breast and Colorectal Cancers
23. Supplementary figure 5 from Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment
24. Supplementary figure 4 from Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment
25. Supplementary figure 3 from Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment
26. Supplementary figure 6 from Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment
27. Supplementary Figure from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
28. Data from Poor-Prognosis Estrogen Receptor–Positive Breast Cancer Identified by Histopathologic Subclassification
29. Supplementary figure 7 from Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment
30. Supplementary Tables 1-2 from Relationship of Extreme Chromosomal Instability with Long-term Survival in a Retrospective Analysis of Primary Breast Cancer
31. Supplementary Figure 1 from Relationship of Extreme Chromosomal Instability with Long-term Survival in a Retrospective Analysis of Primary Breast Cancer
32. Supplementary Figure 4 from Relationship of Extreme Chromosomal Instability with Long-term Survival in a Retrospective Analysis of Primary Breast Cancer
33. Supplementary table 1 from Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment
34. Supplementary Figure Legends 1-4 from Relationship of Extreme Chromosomal Instability with Long-term Survival in a Retrospective Analysis of Primary Breast Cancer
35. Data from Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment
36. Supplementary Figure S1 from Poor-Prognosis Estrogen Receptor–Positive Breast Cancer Identified by Histopathologic Subclassification
37. Supplementary figure 2 from Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment
38. Supplementary figure legends from Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment
39. Supplementary figure 1 from Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment
40. Supplementary Figure 2B from Relationship of Extreme Chromosomal Instability with Long-term Survival in a Retrospective Analysis of Primary Breast Cancer
41. Supplementary Figure 3 from Relationship of Extreme Chromosomal Instability with Long-term Survival in a Retrospective Analysis of Primary Breast Cancer
42. Supplementary Methods from Relationship of Extreme Chromosomal Instability with Long-term Survival in a Retrospective Analysis of Primary Breast Cancer
43. Data from Relationship of Extreme Chromosomal Instability with Long-term Survival in a Retrospective Analysis of Primary Breast Cancer
44. Supplementary Table S1 from Carcinoembryonic Antigen Cell Adhesion Molecule 6 Predicts Breast Cancer Recurrence following Adjuvant Tamoxifen
45. Supplementary Data from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
46. Data from Estrogen Receptor β1 Expression Is Regulated by miR-92 in Breast Cancer
47. Supplementary Table 1 from Estrogen Receptor β1 Expression Is Regulated by miR-92 in Breast Cancer
48. Supplementary Table 2 from Estrogen Receptor β1 Expression Is Regulated by miR-92 in Breast Cancer
49. Supplementary Figure 3 from Estrogen Receptor β1 Expression Is Regulated by miR-92 in Breast Cancer
50. Supplementary Figure 1 from Estrogen Receptor β1 Expression Is Regulated by miR-92 in Breast Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.